Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Clinical trial NCT02912559 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02912559
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Colon Adenocarcinoma DNA Repair Disorder Lynch Syndrome Stage III Colon Cancer AJCC v8

Start date: 2017-10-16
Primary completion: 2025-02-04
Enrollment: 712

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.